
DeepTek celebrates Thai FDA approval for its groundbreaking chest X-ray screening solution, Genki. Genki utilizes advanced AI technology to classify X-ray scans as normal or abnormal while analyzing over 19 chest pathologies. This innovation promises to enhance medical diagnosis and treatment efficiency for global health challenges like tuberculosis, pneumonia, lung cancer, and chronic pulmonary diseases. The company collaborates with top Thai medical institutions for seamless integration, ensuring healthcare providers benefit from AI without disruption.
Like
Save
Share